Extendicare (OTCMKTS:EXETF – Get Free Report) is expected to announce its results after the market closes on Thursday, November 5th. Analysts expect the company to post earnings of $0.2493 per share and revenue of $446.58 million for the quarter.
Extendicare Stock Up 2.3%
Shares of EXETF stock opened at $19.61 on Wednesday. The stock has a 50-day moving average of $20.80 and a 200-day moving average of $21.55. Extendicare has a one year low of $11.06 and a one year high of $28.45.
Analyst Ratings Changes
A number of research analysts recently issued reports on the stock. Royal Bank Of Canada restated an “outperform” rating on shares of Extendicare in a report on Friday, August 14th. Canadian Imperial Bank of Commerce reissued an “outperform” rating on shares of Extendicare in a report on Monday, October 26th. Five analysts have rated the stock with a Buy rating. According to MarketBeat.com, the stock currently has an average rating of “Buy”.
Get Our Latest Report on EXETF
Extendicare Company Profile
Extendicare Inc is a Canadian provider of continuing health care and senior living services. The company operates long-term care homes and retirement communities, serving older adults who require residential care, assistance with daily living, or supportive housing.
Through its ParaMed business, Extendicare also provides home health-care services, including nursing, personal support, rehabilitation, and other care delivered in patients’ homes. In addition, the company offers management and consulting services to health-care and senior living operators through its Extendicare Assist platform.
Extendicare was established in 1968 and serves communities across Canada.
Further Reading
- Five stocks we like better than Extendicare
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
